Search research articles
Contact Us
Filters
Showing results (91-100 of 178) with videos related to
Page
of 18
Sort By:
Journal of Applied Genetics
|
February 12, 2008
Clinical course of homozygous familial hypercholesterolemia during childhood: report on 4 unrelated patients with homozygous or compound heterozygous mutations in the LDLR gene
Jolanta Kubalska, Magdalena Chmara, Janusz Limon, et al.
Journal of Clinical Lipidology
|
February 24, 2019
The clinical and molecular diversity of homozygous familial hypercholesterolemia in children: Results from the GeneTics of clinical homozygous hypercholesterolemia (GoTCHA) study
Ilse K Luirink, Marjet J A M Braamskamp, Albert Wiegman, et al.
The Netherlands Journal of Medicine
|
August 4, 2012
APOE1 mutation in a patient with type III hyperlipoproteinaemia: detailed genetic analysis required
M E Visser, G M Dallinga-Thie, S J Pinto-Sietsma, et al.
Journal of Internal Medicine
|
January 25, 2003
Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia
P R W de Sauvage Nolting, J C Defesche, R J A Buirma, et al.
Journal of Hypertension
|
February 28, 2008
Haplotype of the angiotensinogen gene is associated with coronary heart disease in familial hypercholesterolemia
Jeroen B van der Net, Aaron Isaacs, Geesje M Dallinga-Thie, et al.
European Heart Journal
|
July 3, 2010
A frequent variant in the ABCA1 gene is associated with increased coronary heart disease risk and a better response to statin treatment in familial hypercholesterolemia patients
Jorie Versmissen, Daniëlla M Oosterveer, Mojgan Yazdanpanah, et al.
Circulation. Genomic and Precision Medicine
|
December 19, 2018
A Deep Intronic Variant in LDLR in Familial Hypercholesterolemia
Laurens F Reeskamp, Merel L Hartgers, Jorge Peter, et al.
Human Genetics
|
December 1, 1993
South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch population
J C Defesche, D E van Diermen, P J Lansberg, et al.
Atherosclerosis
|
April 14, 2009
5-Lipoxygenase activating protein (ALOX5AP) gene variants associate with the presence of xanthomas in familial hypercholesterolemia
Daniëlla M Oosterveer, Jorie Versmissen, Mojgan Yazdanpanah, et al.
Journal of Clinical Pharmacology
|
April 1, 1990
Clinical safety of flurbiprofen
C D Brooks, O I Linet, D Schellenberg, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 178) with videos related to
Sort By:
Page
of 18
Journal of Applied Genetics
|
February 12, 2008
Clinical course of homozygous familial hypercholesterolemia during childhood: report on 4 unrelated patients with homozygous or compound heterozygous mutations in the LDLR gene
Jolanta Kubalska, Magdalena Chmara, Janusz Limon, et al.
Journal of Clinical Lipidology
|
February 24, 2019
The clinical and molecular diversity of homozygous familial hypercholesterolemia in children: Results from the GeneTics of clinical homozygous hypercholesterolemia (GoTCHA) study
Ilse K Luirink, Marjet J A M Braamskamp, Albert Wiegman, et al.
The Netherlands Journal of Medicine
|
August 4, 2012
APOE1 mutation in a patient with type III hyperlipoproteinaemia: detailed genetic analysis required
M E Visser, G M Dallinga-Thie, S J Pinto-Sietsma, et al.
Journal of Internal Medicine
|
January 25, 2003
Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia
P R W de Sauvage Nolting, J C Defesche, R J A Buirma, et al.
Journal of Hypertension
|
February 28, 2008
Haplotype of the angiotensinogen gene is associated with coronary heart disease in familial hypercholesterolemia
Jeroen B van der Net, Aaron Isaacs, Geesje M Dallinga-Thie, et al.
European Heart Journal
|
July 3, 2010
A frequent variant in the ABCA1 gene is associated with increased coronary heart disease risk and a better response to statin treatment in familial hypercholesterolemia patients
Jorie Versmissen, Daniëlla M Oosterveer, Mojgan Yazdanpanah, et al.
Circulation. Genomic and Precision Medicine
|
December 19, 2018
A Deep Intronic Variant in LDLR in Familial Hypercholesterolemia
Laurens F Reeskamp, Merel L Hartgers, Jorge Peter, et al.
Human Genetics
|
December 1, 1993
South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch population
J C Defesche, D E van Diermen, P J Lansberg, et al.
Atherosclerosis
|
April 14, 2009
5-Lipoxygenase activating protein (ALOX5AP) gene variants associate with the presence of xanthomas in familial hypercholesterolemia
Daniëlla M Oosterveer, Jorie Versmissen, Mojgan Yazdanpanah, et al.
Journal of Clinical Pharmacology
|
April 1, 1990
Clinical safety of flurbiprofen
C D Brooks, O I Linet, D Schellenberg, et al.
Page
of 18